STOCK TITAN

PROTECT PHARMS (PRTT) Stock News, Mar 2021-Jan 2022

PRTT OTC
Rhea-AI Summary

Protect Pharmaceutical Corp. (OTC: PRTT) has announced its new project, MultiNFT, aimed at creating a multi-chain NFT marketplace. This platform will support multiple blockchains, including Ethereum, Tron, Binance Smart Chain, Solana, and Polygon, allowing users to seamlessly switch between wallets and optimize trading fees. MultiNFT will enable businesses to easily establish their own NFT marketplaces without significant investments in IT infrastructure. The company anticipates that the NFT market could reach an $80 billion valuation, and PRTT is committed to being a key player in this expanding sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.86%
Tags
none
-
Rhea-AI Summary

Protect Pharmaceutical Corp. (PRTT) announced a partnership with Aetsoft, focusing on technology and product development in sectors such as FinTech and Healthcare. This collaboration aims to leverage Aetsoft's expertise in innovative technologies, including AI and blockchain, to enhance product offerings. The companies plan to share knowledge and develop new solutions, driving growth for both parties. Additionally, PRTT aims to combine its financials with Aetsoft to achieve fully-reporting status with the SEC, enhancing transparency and market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.51%
Tags
partnership
-
Rhea-AI Summary

Protect Pharmaceutical Corp. (PRTT) has announced its intention to acquire INAI App Corp, a company specializing in Artificial Intelligence technology. This acquisition includes the innovative 'Human Scanner Software,' designed for security scanning in public venues like airports and hospitals. The software uses advanced computer vision and machine learning to quickly detect threats such as guns and bombs. Following the merger, INAI's founder, Nikolai Grebenkine, will lead the new entity, indicating a promising direction for the technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
partnership acquisition
Rhea-AI Summary

Protect Pharmaceutical Corp (OTC: PRTT) has initiated a turnaround strategy powered by its merger with PUMA, aiming to recover revenue levels of $100 million achieved by PUMA in 2012. The company has consolidated its assets, reducing debt to nearly zero, and plans to introduce innovative green technologies in biopolymers for packaging and industrial design. PRTT anticipates generating profits exceeding $500,000 on revenues of $6 million by the end of 2021, marking the beginning of its revenue growth trajectory.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.96%
Tags
none

FAQ

What is the current stock price of PROTECT PHARMS (PRTT)?

PROTECT PHARMS (PRTT) last closed at $0.13.

What is the market cap of PROTECT PHARMS (PRTT)?

The market cap of PROTECT PHARMS (PRTT) is approximately $7.5M.